MX9303165A - Preparaciones farmaceuticas estables de nicorandil - Google Patents
Preparaciones farmaceuticas estables de nicorandilInfo
- Publication number
- MX9303165A MX9303165A MX9303165A MX9303165A MX9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A MX 9303165 A MX9303165 A MX 9303165A
- Authority
- MX
- Mexico
- Prior art keywords
- nicorandil
- pharmaceutical preparations
- stable
- stable pharmaceutical
- dimethyl polysiloxanes
- Prior art date
Links
- LBHIOVVIQHSOQN-UHFFFAOYSA-N nicorandil Chemical compound [O-][N+](=O)OCCNC(=O)C1=CC=CN=C1 LBHIOVVIQHSOQN-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002497 nicorandil Drugs 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940008099 dimethicone Drugs 0.000 abstract 1
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000009877 rendering Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones estables de nicorandil han sido obtenidas preparando suspensiones de principio activo en dimetil polisiloxanos (dimeticona) a baja densidad para uso farmacéutico, con las cuales han sido llenadas cápsulas blandas o duras de gelatina. Los dimetil polisiloxanos a baja densidad han mostrado de ser químicamente compatibles con nicorandil y de preservar eficazmente de la humedad las preparaciones farmacéuticas así obtenidas, rendiendolas más estables para los normales tiempos de conservación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921413A IT1256022B (it) | 1992-06-08 | 1992-06-08 | Preparazioni farmaceutiche stabili di nicorandil |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9303165A true MX9303165A (es) | 1993-12-31 |
Family
ID=11363474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9303165A MX9303165A (es) | 1992-06-08 | 1993-05-28 | Preparaciones farmaceuticas estables de nicorandil |
Country Status (10)
Country | Link |
---|---|
US (1) | US5580576A (es) |
EP (1) | EP0574221B1 (es) |
JP (1) | JP2893307B2 (es) |
KR (1) | KR100196212B1 (es) |
AT (1) | ATE197671T1 (es) |
DE (1) | DE69329691T2 (es) |
ES (1) | ES2153835T3 (es) |
IT (1) | IT1256022B (es) |
MX (1) | MX9303165A (es) |
PT (1) | PT574221E (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6129673A (en) * | 1998-06-08 | 2000-10-10 | Advanced Monitors, Corp. | Infrared thermometer |
JP4472035B2 (ja) * | 1998-06-17 | 2010-06-02 | 森下仁丹株式会社 | 長期保存安定性に優れたカプセル製剤 |
US20040151785A1 (en) * | 1998-10-06 | 2004-08-05 | Diamedica Inc. | Method for treating insulin resistance through hepatic nitric oxide |
AU3810100A (en) * | 1999-03-12 | 2000-10-04 | Basf Aktiengesellschaft | Stable pharmaceutical application form for paroxetin anhydrate |
WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
FR2850275B1 (fr) * | 2003-01-24 | 2005-04-08 | Scherer Technologies Inc R P | Capsules molles a macher contenant une substance active a gout masque |
DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
JP4740740B2 (ja) | 2003-12-09 | 2011-08-03 | 大日本住友製薬株式会社 | 薬物含有粒子および該粒子を含む固形製剤 |
ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
US20070281008A1 (en) * | 2006-06-05 | 2007-12-06 | Lin Shun Y | Personal lubricant compositions and kits for providing personal lubrication |
US20140044779A1 (en) * | 2011-04-18 | 2014-02-13 | Lipidor Ab | Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent |
WO2013173923A1 (en) | 2012-05-25 | 2013-11-28 | Diamedica, Inc. | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
ES2625548T3 (es) | 2012-06-04 | 2017-07-19 | DiaMedica Therapeutics Inc. | Isoformas de glicosilación de la calicreína-1 tisular humana |
KR20190122706A (ko) | 2017-03-09 | 2019-10-30 | 다이어메디카 인코포레이티드 | 조직 칼리크레인 1의 투약 형태 |
CN110123749B (zh) * | 2019-06-03 | 2022-01-25 | 太阳升(亳州)生物医药科技有限公司 | 尼可地尔脂微球制剂及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223811A1 (en) * | 1985-05-22 | 1987-06-03 | Beecham Group Plc | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
US5188840A (en) * | 1985-09-26 | 1993-02-23 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
JPS6351326A (ja) * | 1986-08-22 | 1988-03-04 | Nisshin Flour Milling Co Ltd | ニコランジル外用剤 |
US5057317A (en) * | 1987-03-24 | 1991-10-15 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
US4837029A (en) * | 1987-04-06 | 1989-06-06 | Carolina Medical Products, Inc. | Low foaming, aqueously homogenizable rifampin composition |
FR2624012B1 (fr) * | 1987-12-07 | 1991-05-31 | Fdb Ste Civile Rech | Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
-
1992
- 1992-06-08 IT ITMI921413A patent/IT1256022B/it active IP Right Grant
-
1993
- 1993-05-28 MX MX9303165A patent/MX9303165A/es not_active IP Right Cessation
- 1993-06-03 JP JP5133290A patent/JP2893307B2/ja not_active Expired - Fee Related
- 1993-06-07 KR KR1019930010224A patent/KR100196212B1/ko not_active IP Right Cessation
- 1993-06-08 EP EP93304427A patent/EP0574221B1/en not_active Expired - Lifetime
- 1993-06-08 AT AT93304427T patent/ATE197671T1/de not_active IP Right Cessation
- 1993-06-08 DE DE69329691T patent/DE69329691T2/de not_active Expired - Fee Related
- 1993-06-08 US US08/073,054 patent/US5580576A/en not_active Expired - Fee Related
- 1993-06-08 ES ES93304427T patent/ES2153835T3/es not_active Expired - Lifetime
- 1993-06-08 PT PT93304427T patent/PT574221E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
JP2893307B2 (ja) | 1999-05-17 |
PT574221E (pt) | 2001-04-30 |
ITMI921413A1 (it) | 1993-12-08 |
ITMI921413A0 (it) | 1992-06-08 |
KR100196212B1 (ko) | 1999-06-15 |
IT1256022B (it) | 1995-11-20 |
US5580576A (en) | 1996-12-03 |
DE69329691T2 (de) | 2001-05-10 |
ES2153835T3 (es) | 2001-03-16 |
DE69329691D1 (de) | 2000-12-28 |
EP0574221B1 (en) | 2000-11-22 |
JPH0640916A (ja) | 1994-02-15 |
EP0574221A1 (en) | 1993-12-15 |
KR940000104A (ko) | 1994-01-03 |
ATE197671T1 (de) | 2000-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9303165A (es) | Preparaciones farmaceuticas estables de nicorandil | |
KE3164A (en) | Optically active substituted-cyano-phenoxybenzyl isovalerates,their preparation and insecticidal compositions containing them | |
ES2187749T3 (es) | Composicion agroquimica envasada. | |
IT1230742B (it) | Composizione per aerosol comprendente nitroglicerina come ingrediente attivo. | |
MX9203480A (es) | Formulaciones medicinales en aereosol. | |
IT1203515B (it) | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono | |
ES2145836T3 (es) | Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel. | |
GR3022641T3 (en) | Stabilization of fluorocarbon emulsions. | |
PT91246A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo | |
IL53594A (en) | Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them | |
MX9203504A (es) | Complejo agente: lipido activo de alta proporcion. | |
PT100928A (pt) | Derivados de ciclopentano e ciclopenteno, composicoes farmaceuticas contendo estes compostos e seu uso | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
MX9205384A (es) | Dispositivo de administracion transdermica de un agente activo para uso veterinario. | |
MXPA97007996A (es) | Preparado para el transporte de sustancias activas a traves de barreras. | |
ATE301986T1 (de) | Kosmetische stiftzubereitung | |
ATE72924T1 (de) | Fungizide wirkstoffgemische. | |
DE69102704D1 (de) | Orales, melatonin enthaltendes arzneimittel. | |
GB8900760D0 (en) | Synergistic fungicidal and acaricidal and compositions containing two or three active ingredients | |
BR8802557A (pt) | Agente fisiologicamente ativo para uso agricola | |
ES2124222T3 (es) | Agentes edulcorantes de clorodesoxiazucar estabilizados en forma solida y procedimientos para su preparacion. | |
NO882509D0 (no) | Nye pyrazolforbindelser og herbicide preparater inneholdende dem som aktive bestanddeler. | |
DK0693926T3 (da) | Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel. | |
MX164799B (es) | Composiciones que contienen azufre activo | |
GB2021409A (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |